• Metastatic Anaplastic Carcinoma of the Small Intestine Arising from The Lung

• Kim DY

• Joo JK/Ryu SY/Kim YJ/Kim SK/Juhng SW

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 364 ~ 366

• The Expressions of Cytokeratin 7 and 20 in Epithelial Tumors: A Survey of 91 Cases

• Kim DH

• Joo JE/Kim EK/Lee HJ/Lee WM

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 355 ~ 363

• Clinical Value of Whole Body F-18 FDG PET in The Management of Recurrent Colorectal Malignancy

• Lim SB

• Choi HS/Kang SB/Heo SC/Park YJ/Jeong SY/Park KJ/Yang HK/Hwang KH/Jeong JM/Lee DS/Chung JK/Lee MC/Kang KW/Park JG

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 349 ~ 354

• TRAIL-Mediated Apoptosis in Human Liver Chang Cells

• Park C

• Hong SW/Jin SH/Kim NS/Cho KH/Cheon JH/Ahn JY/Yang JK/Park R

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 341 ~ 348

• Clinical Significance of the Levels of Serum Cholesterol in Patients with Gastric Cancer

• Kim Tae-Hyo

• Ahn Sung-Jin, Jung Woon-Tae, Lee Ok-Jae, Ha Woo-Song, Jang Joung-Soon

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 335 ~ 340

• Concurrent FP (5-fluorouracil, cisplatin) Chemoradiotherapy for Patients with Esophageal Cancer

• Kim MO

• Hong ES/Chai JY/Leem JM/You IY/Kim WD/Park WY/Kim ST/Lee KH

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 330 ~ 334

• Prognostic Significance of KAI-1 and Survivin Expressions in Ovarian Epithelial Carcinomas

• Lee JH

• Lee SM/Choi JS

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 323 ~ 329

• Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes i...

• Lee C

• Kim SJ/Na JY/Park CS/Lee SY/Kim IH/Oh YK

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 314 ~ 322

• New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene On...

• Kim YW

• Suh MJ/Bae JS/Bae SM/Yoon JH/Hur SY/Kim JH/Ro DY/Lee JM/Namkoong SE/Kim CK/Ahn WS

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 304 ~ 313

• Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small...

• Kang HJ

• Kim MK/Kim YG/Lee JL/Lee KH/Hyun MS/Bae SH/Ryoo HM

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 299 ~ 303

• Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Can...

• Kim YJ

• Sohn JH/Kim C/Kim YT/Kim HJ/Ahn JB/Kim SK/Chang J/Yoo NC/Kim JH/Cho JY

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 294 ~ 298

• Microsatellite Alterations in Serum DNA of Lung Cancer Patients

• Oh SC

• Yoo YD/Yoon SY/Kim SJ/Seo JH/Kim KT/Shin SW/Kim YH/Kim JS

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 289 ~ 293

• Advances in Nuclear Oncology

• Kim EE

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 281 ~ 288

• Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Fu...

• Park K

• ´ëÇѾÏÇÐȸÁö   2003  Volume.35  No.4 279 ~ 280